Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Second-Generation TKIs Join Imatinib as Front-Line Treatment for CML
Link ID 34412
Title Second-Generation TKIs Join Imatinib as Front-Line Treatment for CML
Url http://www.medscape.com/viewarticle/738892?src=rss
Description Updated NCCN guidelines for chronic myelogenous leukemia (CML) name the second-generation tyrosine kinase inhibitors (TKIs) nilotinib and dasatinib as front-treatment for CML. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Mar 15, 2011
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. BK Virus May Play Role in Prostate Cancer
  BK virus may act as a cofactor in prostate cancer pathogenesis, according to a report in the December issue of the Journal of Medical Virology. Reuters Health Information
Category:   Articles > Hematology-Oncology


2. Detection and Significance of Donath-Landsteiner Antibodies in a 5-year-old Female Presenting With H
  A rare case of a 5-year-old who presented with hemolytic anemia and was subsequently diagnosed with paroxysmal cold hemoglobinuria. Laboratory Medicine
Category:   Articles > Hematology-Oncology


3. Chemo Toxicity May Tip Scales in Advanced Hodgkins LymphomaChemo Toxicity May Tip Scales in Advanced
  Overall survival nearly evened out in a clinical trial comparing 2 chemotherapy regimens; adverse events might be a deciding factor in choosing one or the other. br / iMedscape Medical News/i
Category:   Articles > Hematology-Oncology


4. p16INK4a Expression Analysis as an Ancillary Tool for Cytologic Diagnosis of Urothelial Carcinoma
  Is immunocytologic analysis of p16INK4a expression in cytologic samples useful in detecting urothelial carcinoma and its infiltrating potential? American Journal of Clinical Pathology
Category:   Articles > Hematology-Oncology


5. AZURE Results Show No Effect of Zolendronic Acid on Breast Cancer
  However, subgroup analyses showed a significant effect on overall survival and disease-free survival in women 5 years after menopause. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS